It was announced this week that Zosano Pharma, Inc. (Zosano) and Asahei Kasei Pharma (AKP) formed a collaboration to develop Teribone (teriparatide acetate), a transdermal patch treatment for osteoporosis.
Minnesota-based orthopedics startup Dgimed Ortho is seeking to raise $2 million for its bone-fracture system.
It’s not hard to convince a patient who is in pain to take his or her medication, but what about the patient who doesn’t feel any symptoms?
Predictive medicine is being hailed as a potential weapon in the fight to control healthcare costs.
Osteologix is positioning NB S101 as an alternative to traditional osteoporosis treatments.
Copyright © 2025 | WordPress Theme by MH Themes